Comparison of GI levels of superfine sugar and fructose in patients with type 2 diabetes or impaired glucose tolerance - Comparison of GI levels of superfine sugar and fructose in patients with type 2 diabetes or impaired glucose tolerance

InCROM Inc.0 个研究点目标入组 48 人开始时间: 2019年9月6日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•(1) Present or history of hepatic disorder, renal disorder, cardiovascular disease, respiratory disease, endocrine system disease, metabolic disease, neurological disease, or psychiatric disease which is not relevant for enrollment in the study as determined by the principal investigator or sub-investigator during the pre-study examinations (2) Present or history of serious allergy or hypersensitivity (3) Known allergic symptoms or aggravation of such symptoms when consuming sugar or a similar product (4) Present or history of drug or alcohol dependence (5) Medical treatment for diabetes with: a) insulin b) GLP-1 receptor agonist, or c) thiazolidine compound (6) Medical treatment for diabetes with 2 or more medications (7) Blood glucose level exceeding 200 mg/dL by self-measured glucometer before ingest of the reference diet (8) Other subjects who are not eligible for the study as determined by the investigator

发起方